К содержанию
РецензированоEN2025

THE EFFECTIVENESS OF NOOTROPIC THERAPY IN PATIENTS WITH RHEUMATIC DISEASES: A CLINICAL ANALYSIS

Khamrayev Khamza Khamidullayevich · Khamraev Botirjon

Современное образование и развитие · 2025

Аннотация

Background: Rheumatic diseases are often accompanied not only by systemic inflammation and joint dysfunction but also by neuropsychiatric symptoms such as cognitive impairment, chronic fatigue, and mood disorders. These manifestations may significantly reduce patients' quality of life and complicate disease management. Objective: This study aims to evaluate the clinical effectiveness of nootropic therapy in patients with various rheumatic diseases and to assess its impact on cognitive function and overall disease course. Methods: A cohort of patients diagnosed with rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis was observed. Nootropic agents such as piracetam, citicoline, and phenibut were administered as adjunctive therapy over a 12-week period. Clinical parameters, cognitive test scores, and patient-reported outcomes were analyzed before and after intervention. Results: The use of nootropic therapy led to statistically significant improvements in cognitive performance, particularly in memory, attention, and mental processing speed. Additionally, patients reported reduced fatigue and improved emotional stability. No severe adverse effects were observed during the course of treatment. Conclusion: Nootropic agents may represent a promising adjunctive approach in the management of rheumatic diseases, particularly in addressing cognitive and neuropsychiatric comorbidities. Further randomized controlled trials are warranted to confirm these findings and determine long-term efficacy and safety. Выпуск журнала №-23 Часть–4_ Апрель –2025 384 MODERN EDUCATION AND DEVELOPMENT Keywords: rheumatic diseases, nootropic therapy, cognitive impairment, neuropsychiatric symptoms, piracetam, citicoline

Доказательный фрагмент

«Background: Rheumatic diseases are often accompanied not only by systemic inflammation and joint dysfunction but also by neuropsychiatric symptoms such as cognitive impairment, chronic fatigue, and mood disorders.»

Образец извлечения

Демо-превью

Background: Rheumatic diseases are often accompanied not only by systemic inflammation and joint dysfunction but also by neuropsychiatric symptoms such as cognitive impairment, chronic fatigue, and mood disorders. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

Цитирований
0
Просмотров
0
Тип
Журнал
Страна
Узбекистан
Ключевые слова
rheumatic diseases, nootropic therapy, cognitive impairment
Открыть DOI
Спросить CiteX об этой работе

Смежные источники